Expression profiling of CD133+ glioma TSC demonstrates a 32-fold increase in the level of MGMT transcripts relative to CD133- tumor cells and indicates that this resistance mechanism is highly active in the glioma TSC population [32]. Here, PROM1 is linked to glioma.